PET scan can non invasively measure early assessment of treatment for common type of breast cancer
Tuesday, May 26, 2009 - 13:42
in Health & Medicine
Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting next week.
Read the whole article on Physorg
More from Physorg
Related
- PET scan can non invasively measure early assessment of treatment for common type of breast cancerTue, 26 May 2009, 12:43:21 EDT
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- LSUHSC research discovers new targets for treatment of invasive breast cancerWed, 19 Aug 2009, 15:45:31 EDT
- Research needed to learn which DCIS patients may be candidates for less invasive therapyFri, 25 Sep 2009, 10:52:35 EDT